Ms. Suzanne Strange, M.ED. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 Isaac Lucas Cir, Dover, NH 03820 Phone: 603-512-9955 |
Holly Pf Goodell, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-740-2101 |
Kristin A Macinnis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 750 Central Ave, Suite C, Dover, NH 03820 Phone: 603-926-3277 |
Mrs. Allison Marie Smick, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Main St, Suite 100, Dover, NH 03820 Phone: 603-609-5685 |
Ms. Ann M Mckone, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 307 Plaza Dr, Dover Rehabilitation And Living Center, Dover, NH 03820 Phone: 603-749-1519 Fax: 603-834-6991 |
Sarah Heymans Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Saint Thomas St, Dover, NH 03820 Phone: 603-740-3534 Fax: 603-740-3684 |
Kassie Nicole Zukowski, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 Chestnut St., Unit 3, Dover, NH 03820 Phone: 603-842-4924 |
Mrs. Ashlie Warren Peters, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42 Dover Point Rd Unit M, Dover Point Office Park, Dover, NH 03820 Phone: 603-969-5063 Fax: 603-740-0060 |
Mrs. Gioia Barbara Schultz, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5 Watson Rd, Dover, NH 03820 Phone: 603-742-5534 |
Lucille Fracasso Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 51 Webb Pl Ste 310, Dover, NH 03820 Phone: 603-842-4924 |
News Archive
The London School of Hygiene and Tropical Medicine's Professor Chris Curtis has joined the Earth Institute's Professor Jeffrey Sachs to call for the mass distribution of free insecticidal bed nets to replace social marketing as a means of controlling malaria in Africa.
Endo International plc today announced it has entered into a definitive agreement under which Endo will acquire Grupo Farmaceutico Somar, a leading privately-owned specialty pharmaceuticals company based in Mexico City, Mexico, for cash consideration. Endo expects the transaction to be immediately accretive to adjusted earnings per share.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
Humour therapy is as effective as widely used antipsychotic drugs in managing agitation in patients with dementia - and avoids serious drug side effects, a new study shows.
› Verified 7 days ago